People with early-stage Parkinson’s disease may be about 70% less likely to catch the common cold than those with…
Margarida Maia, PhD
Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Maia, PhD
Krill oil, which comes from a shrimp-like animal, protected dopamine-producing neurons from age-related degeneration and boosted neurologic processes dependent on…
A gene therapy designed to track down and keep overactive brain cells in check was able to lower the number…
Add-on treatment with a low dose of zonisamide, an anti-seizure medication, failed to significantly ease tremor in a pilot…
A request to launch a first Phase 1/2 clinical trial of a stem cell-based therapy in people with Parkinson’s…
Using simulated images, researchers have developed a method that may allow them to quantify how much dopamine transporter — a…
People who go on to develop a neurodegenerative disease such as Parkinson’s may experience poorer overall health and show…
Two small molecules in the pipeline of Lucy Therapeutics helped nerve cells (neurons) keep their mitochondria healthier and…
Gb Sciences has identified a handful of mixtures that contain just enough  cannabinoids — the active compounds of the…
Dosing has begun in LIGHTHOUSE, a Phase 3 clinical trial testing BIIB122 — an experimental inhibitor of LRRK2 being developed…